Your browser doesn't support javascript.
loading
Anlotinib in patients with recurrent platinum resistant/refractory ovarian cancer: a prospective, single arm, phase II study.
Shen, Wenbin; Jing, Chuyu; Tian, Wenjuan; Zhang, Wei; Ren, Yulan; Shan, Boer; Wang, Huaying.
Afiliação
  • Shen W; Department of Gynecologic Oncology, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China.
  • Jing C; Department of Gynecologic Oncology, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China.
  • Tian W; Department of Gynecologic Oncology, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhang W; Department of Gynecologic Oncology, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China.
  • Ren Y; Department of Gynecologic Oncology, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China.
  • Shan B; Department of Gynecologic Oncology, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China shanboer@hotmail.com wanghuaying270@163.com.
  • Wang H; Department of Gynecologic Oncology, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China shanboer@hotmail.com wanghuaying270@163.com.
Int J Gynecol Cancer ; 33(11): 1764-1770, 2023 11 06.
Article em En | MEDLINE | ID: mdl-37775281

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Idioma: En Ano de publicação: 2023 Tipo de documento: Article